As of April 22, 2026, United Therapeutics's top three insider holders are Martine A Rothblatt (Chairperson Ceo, 644.18K shares), Martine A Rothblatt (Chairperson Ceo, 324.44K shares), Martine A Rothblatt (Chairperson Ceo, 258.12K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Martine A Rothblatt | Chairperson Ceo | 0 | 644,183 | 22 Dec, 2022 |
| Martine A Rothblatt | Chairperson Ceo | 0 | 324,443 | 16 Apr, 2026 |
| Martine A Rothblatt | Chairperson Ceo | 0 | 258,117 | 11 Mar, 2025 |
| Paul A Mahon | Evp General Counsel | 45,172 | 0 | 16 Apr, 2026 |
| Martine A Rothblatt | Chairperson Ceo | 40,513 | 0 | 14 Apr, 2026 |
| Richard Giltner | - | 20,574 | 0 | 25 Jul, 2025 |
| Michael Benkowitz | President And Coo | 0 | 19,046 | 17 Mar, 2026 |
| James Edgemond | Cfo And Treasurer | 18,876 | 0 | 14 Apr, 2026 |
| Richard Giltner | - | 13,870 | 0 | 08 Jul, 2022 |
| Ray Kurzweil | - | 12,670 | 0 | 05 Mar, 2026 |
| Martine A Rothblatt | Chairperson Ceo | 0 | 10,962 | 10 Dec, 2025 |
| Tommy G Thompson | - | 8,480 | 0 | 26 Mar, 2026 |
| Nilda Mesa | - | 5,286 | 0 | 10 Dec, 2025 |
| Judy D. Olian | - | 4,245 | 0 | 24 Mar, 2026 |
| Christopher Causey | - | 4,190 | 0 | 30 Mar, 2026 |
| Katherine J Klein | - | 3,640 | 0 | 11 Mar, 2024 |
| Louis W Sullivan | - | 3,200 | 0 | 19 Dec, 2024 |
| Michael Benkowitz | President And Coo | 2,577 | 0 | 07 May, 2024 |
| Raymond Dwek | - | 1,750 | 0 | 22 Apr, 2025 |
| Christopher Patusky | - | 1,490 | 0 | 16 Dec, 2025 |
| Christopher Patusky | - | 0 | 1,100 | 18 Nov, 2022 |
| Jan Malcolm | - | 125 | 0 | 17 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 Apr, 2026 | Paul A Mahon | Common Stock | A | 8,300 | $146.03 | 53,472 | D | M |
| 13 Mar, 2026 | Martine A Rothblatt | Common Stock | D | 75 | $536.95 | 324,443 | I | S |
| 14 Apr, 2026 | Martine A Rothblatt | Common Stock | A | 9,500 | $146.03 | 50,013 | D | M |
| 16 Apr, 2026 | Paul A Mahon | Common Stock | D | 200 | $574.03 | 53,272 | D | S |
| 16 Apr, 2026 | Paul A Mahon | Common Stock | D | 1,640 | $575.37 | 51,632 | D | S |
| 14 Apr, 2026 | Martine A Rothblatt | Common Stock | D | 280 | $574.25 | 49,733 | D | S |
| 14 Apr, 2026 | Martine A Rothblatt | Common Stock | D | 404 | $575.25 | 49,329 | D | S |
| 16 Apr, 2026 | Paul A Mahon | Common Stock | D | 1,800 | $576.38 | 49,832 | D | S |
| 16 Apr, 2026 | Paul A Mahon | Common Stock | D | 3,366 | $577.39 | 46,466 | D | S |
| 14 Apr, 2026 | Martine A Rothblatt | Common Stock | D | 80 | $575.90 | 49,249 | D | S |
| 14 Apr, 2026 | Martine A Rothblatt | Common Stock | D | 1,360 | $577.62 | 47,889 | D | S |
| 16 Apr, 2026 | Paul A Mahon | Common Stock | D | 1,294 | $578.21 | 45,172 | D | S |
| 16 Apr, 2026 | Paul A Mahon | Stock Option | D | 8,300 | $0.00 | 8,600 | D | M |
| 14 Apr, 2026 | Martine A Rothblatt | Common Stock | D | 1,164 | $578.41 | 46,725 | D | S |
| 14 Apr, 2026 | Martine A Rothblatt | Common Stock | D | 1,580 | $579.65 | 45,145 | D | S |
| 14 Apr, 2026 | Martine A Rothblatt | Common Stock | D | 3,675 | $580.55 | 41,470 | D | S |
| 14 Apr, 2026 | Martine A Rothblatt | Common Stock | D | 957 | $581.50 | 40,513 | D | S |
| 15 Apr, 2026 | Martine A Rothblatt | Common Stock | A | 9,500 | $146.03 | 50,013 | D | M |
| 15 Apr, 2026 | Martine A Rothblatt | Common Stock | D | 80 | $575.29 | 49,933 | D | S |
| 15 Apr, 2026 | Martine A Rothblatt | Common Stock | D | 880 | $576.98 | 49,053 | D | S |